PRESS RELEASE

Anna Carpio Joins Pittsburgh-Based Contract Research Organization, Clinical Research Strategies, LLC as Clinical Research Associate

Pittsburgh, PA – December 6, 2023. Clinical Research Strategies, LLC (“CRS”), a Pittsburgh-area-based, US-owned and operated contract research organization (CRO) and executive management consultancy for the life sciences industry is pleased to announce the addition of Anna Carpio, Clinical Research Associate (CRA), to the firm. Ms. Carpio earned a bachelor’s degree in psychology Cum Laude with Honors in 2023, from the University of Pittsburgh, and established an interest in neuroscience research with brain injury patients. Anna worked for Dr. Anthony Kline at the Safar Research Center, where she studied the effects of pharmaceuticals on experimental traumatic brain injuries. Through this research, she had the opportunity to attend the SACNAS conference as a Travel Scholar and won an Outstanding Research Presentation award.

Anna Carpio

Photo by Jen Worley

She was recently published as a corresponding author in Experimental Neurology, for her research contributions to “A bridge to recovery: acute amantadine prior to environmental enrichment after brain trauma augments cognitive benefit.” Anna has experience as a clinical assistant in rehabilitating TBI patients, and as a peer specialist at Western Psychiatric Hospital, furthering her passion for neuroscience and psychology. In her free time, Anna loves to play soccer, weightlift, and try new recipes. In her last year at Pitt, she was the president of the recreational soccer club.

“Ms. Carpio is a great example of a new graduate whose professional interests are to enter the life sciences sector knowing what challenges lie ahead in the industry, including with artificial intelligence and machine learning,” says Alethea Wieland, CRS President and Founder. CEO, David Link, MBA adds, “We are excited that Anna joins us at a time of significant transformation in decentralized clinical research and regulatory reform, and look forward to mentoring her team relationship and leadership skills.”

About Clinical Research Strategies, LLC:

CRS is a specialty CRO and executive management consulting firm that fits-for-purpose veteran life sciences executives, attorneys, regulatory scientists and strategists, clinical operations, project management, quality assurance engineers, and sales and marketing teams to take on the biggest challenges for start-up, mid-sized, and large life sciences companies, many of whom are developing novel, first-in-class drugs, biologics, diagnostics and medical devices, or software as a medical device (SaMD). Service areas are clinical trials, Functional Service Provider (FSP) models, selection and management of CROs, regulatory compliance strategy and submissions, QMS, EU MDR and GDPR, rescue trials, TMF, risk mitigation and remediation, training high-performing teams, staffing solutions, and decentralized trials.

Indications represented are precision medicine, immuno-oncology, central nervous system, infectious diseases, respiratory diseases, orthopedics, de novo devices, digital health and mobile apps, reproductive health, regenerative medicine, cardiology, major depressive disorder, opioid-sparing pain, cannabis, radiology, and critical care. CRS is a qualified service provider for federal grants.

CRS is an inclusive employer and does not discriminate in employment on the basis of race, color, religion, sex, gender identity, national origin, political affiliation, sexual orientation, marital status, disability, genetic information, age, education, membership in an employee organization, parental status, military service, vaccine status, or other non-merit factor. CRS does not tolerate censorship, surveillance, bullying, intimidation, retaliation, discrimination, or harassment of any kind.

# # #

Media Contact:
Ron MacDonald
Step2 Branding and Design
ronmac@step2branding.com
+1 724.814.4067

Alethea Wieland, President and Founder
Clinical Research Strategies, LLC
alethea@clinicalresearchstrategies.com
+1 724.272.1245

 

Download this press release as a PDF.

Share This